chrX-13600045-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_015507.4(EGFL6):c.351G>A(p.Lys117=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00477 in 1,209,514 control chromosomes in the GnomAD database, including 131 homozygotes. There are 1,574 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.022 ( 65 hom., 689 hem., cov: 22)
Exomes 𝑓: 0.0030 ( 66 hom. 885 hem. )
Consequence
EGFL6
NM_015507.4 synonymous
NM_015507.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.82
Genes affected
EGFL6 (HGNC:3235): (EGF like domain multiple 6) This gene encodes a member of the epidermal growth factor (EGF) repeat superfamily. Members of this superfamily are characterized by the presence of EGF-like repeats and are often involved in the regulation of cell cycle, proliferation, and developmental processes. The gene product contains a signal peptide, suggesting that it is secreted; an EGF repeat region consisting of 4 complete EGF-like repeats and 1 partial EGF-like repeat, 3 of which have a calcium-binding consensus sequence; an arg-gly-asp integrin association motif; and a MAM domain, which is believed to have an adhesive function. This gene is expressed early during development, and its expression has been detected in lung and meningioma tumors. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant X-13600045-G-A is Benign according to our data. Variant chrX-13600045-G-A is described in ClinVar as [Benign]. Clinvar id is 780682.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.82 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0734 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EGFL6 | NM_015507.4 | c.351G>A | p.Lys117= | synonymous_variant | 4/12 | ENST00000361306.6 | |
EGFL6 | NM_001167890.2 | c.351G>A | p.Lys117= | synonymous_variant | 4/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EGFL6 | ENST00000361306.6 | c.351G>A | p.Lys117= | synonymous_variant | 4/12 | 1 | NM_015507.4 | A2 | |
EGFL6 | ENST00000380602.3 | c.351G>A | p.Lys117= | synonymous_variant | 4/12 | 1 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0223 AC: 2493AN: 111724Hom.: 64 Cov.: 22 AF XY: 0.0200 AC XY: 678AN XY: 33886
GnomAD3 genomes
AF:
AC:
2493
AN:
111724
Hom.:
Cov.:
22
AF XY:
AC XY:
678
AN XY:
33886
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00735 AC: 1344AN: 182950Hom.: 31 AF XY: 0.00466 AC XY: 314AN XY: 67444
GnomAD3 exomes
AF:
AC:
1344
AN:
182950
Hom.:
AF XY:
AC XY:
314
AN XY:
67444
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00297 AC: 3257AN: 1097739Hom.: 66 Cov.: 30 AF XY: 0.00244 AC XY: 885AN XY: 363155
GnomAD4 exome
AF:
AC:
3257
AN:
1097739
Hom.:
Cov.:
30
AF XY:
AC XY:
885
AN XY:
363155
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0224 AC: 2509AN: 111775Hom.: 65 Cov.: 22 AF XY: 0.0203 AC XY: 689AN XY: 33947
GnomAD4 genome
AF:
AC:
2509
AN:
111775
Hom.:
Cov.:
22
AF XY:
AC XY:
689
AN XY:
33947
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 11, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at